493
Views
6
CrossRef citations to date
0
Altmetric
Cardiology: Review

Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients)

&
Pages 41-53 | Accepted 14 Nov 2012, Published online: 06 Dec 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Julian Segura & Luis Miguel Ruilope. (2013) A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide. Vascular Health and Risk Management 9, pages 521-528.
Read now
Niki Katsiki, Vasilios G. Athyros & Asterios Karagiannis. (2013) Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?. Journal of Drug Assessment 2:1, pages 67-71.
Read now

Articles from other publishers (4)

Claudio Napoli, Stefano Omboni & Claudio Borghi. (2016) Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic Syndrome). Journal of Hypertension 34:11, pages 2287-2297.
Crossref
Jie Peng, Yingxin Zhao, Hua Zhang, Zhendong Liu, Zhihao Wang, Mengxiong Tang, Ming Zhong, Fanghong Lu & Wei Zhang. (2014) Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure. Hypertension Research 38:2, pages 123-131.
Crossref
Dingliang Zhu, Pingjin Gao, Werner Holtbruegge & Chenglei Huang. (2014) A randomized, double-blind study to evaluate the efficacy and safety of a single-pill combination of telmisartan 80 mg/amlodipine 5 mg versus amlodipine 5 mg in hypertensive Asian patients. Journal of International Medical Research 42:1, pages 52-66.
Crossref
Dingliang Zhu, Pingjin Gao, Nobutaka Yagi & Helmut Schumacher. (2014) Efficacy and Tolerability of Telmisartan Plus Amlodipine in Asian Patients Not Adequately Controlled on Either Monotherapy or on Low-Dose Combination Therapy. International Journal of Hypertension 2014, pages 1-11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.